145 related articles for article (PubMed ID: 11392544)
1. Pharmacological evaluation of a diarylmethylene-piperidine derivative: a new potent atypical antipsychotic?
Talaga P; Matagne A; Klitgaard H
Bioorg Med Chem Lett; 2001 May; 11(10):1313-6. PubMed ID: 11392544
[TBL] [Abstract][Full Text] [Related]
2. New antipsychotic agents with serotonin and dopamine antagonist properties based on a pyrrolo[2,1-b][1,3]benzothiazepine structure.
Campiani G; Nacci V; Bechelli S; Ciani SM; Garofalo A; Fiorini I; Wikström H; de Boer P; Liao Y; Tepper PG; Cagnotto A; Mennini T
J Med Chem; 1998 Sep; 41(20):3763-72. PubMed ID: 9748351
[TBL] [Abstract][Full Text] [Related]
3. Serotonin 5-HT2 receptor, dopamine D2 receptor, and alpha 1 adrenoceptor antagonists. Conformationally flexible analogues of the atypical antipsychotic sertindole.
Andersen K; Liljefors T; Hyttel J; Perregaard J
J Med Chem; 1996 Sep; 39(19):3723-38. PubMed ID: 8809161
[TBL] [Abstract][Full Text] [Related]
4. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
[TBL] [Abstract][Full Text] [Related]
5. N-Substituted (2,3-dihydro-1,4-benzodioxin-2-yl)methylamine derivatives as D(2) antagonists/5-HT(1A) partial agonists with potential as atypical antipsychotic agents.
Birch AM; Bradley PA; Gill JC; Kerrigan F; Needham PL
J Med Chem; 1999 Aug; 42(17):3342-55. PubMed ID: 10464021
[TBL] [Abstract][Full Text] [Related]
6. Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity.
Leysen JE; Janssen PM; Megens AA; Schotte A
J Clin Psychiatry; 1994 May; 55 Suppl():5-12. PubMed ID: 7520908
[TBL] [Abstract][Full Text] [Related]
7. Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors.
Stockmeier CA; DiCarlo JJ; Zhang Y; Thompson P; Meltzer HY
J Pharmacol Exp Ther; 1993 Sep; 266(3):1374-84. PubMed ID: 8103793
[TBL] [Abstract][Full Text] [Related]
8. Conformationally constrained butyrophenones with affinity for dopamine (D(1), D(2), D(4)) and serotonin (5-HT(2A), 5-HT(2B), 5-HT(2C)) receptors: synthesis of aminomethylbenzo[b]furanones and their evaluation as antipsychotics.
Raviña E; Casariego I; Masaguer CF; Fontenla JA; Montenegro GY; Rivas ME; Loza MI; Enguix MJ; Villazon M; Cadavid MI; Demontis GC
J Med Chem; 2000 Nov; 43(24):4678-93. PubMed ID: 11101359
[TBL] [Abstract][Full Text] [Related]
9. Discovery of aryl-piperidine derivatives as potential antipsychotic agents using molecular hybridization strategy.
Zhu C; Li X; Zhao B; Peng W; Li W; Fu W
Eur J Med Chem; 2020 May; 193():112214. PubMed ID: 32182489
[TBL] [Abstract][Full Text] [Related]
10. 3-[[(Aryloxy)alkyl]piperidinyl]-1,2-benzisoxazoles as D2/5-HT2 antagonists with potential atypical antipsychotic activity: antipsychotic profile of iloperidone (HP 873).
Strupczewski JT; Bordeau KJ; Chiang Y; Glamkowski EJ; Conway PG; Corbett R; Hartman HB; Szewczak MR; Wilmot CA; Helsley GC
J Med Chem; 1995 Mar; 38(7):1119-31. PubMed ID: 7707315
[TBL] [Abstract][Full Text] [Related]
11. Potential role of 5-HT2 and D2 receptor interaction in the atypical antipsychotic action of the novel succimide derivative, perospirone.
Ohno Y; Ishida-Tokuda K; Ishibashi T; Sakamoto H; Tagashira R; Horisawa T; Yabuuti K; Matsumoto K; Kawabe A; Nakamura M
Pol J Pharmacol; 1997 Aug; 49(4):213-9. PubMed ID: 9437764
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of a series of piperidine-2,6-dione-piperazine (piperidine) derivatives as multireceptor atypical antipsychotics.
Chen Y; Xu X; Liu X; Liu BF; Zhang G
Arch Pharm (Weinheim); 2012 Nov; 345(11):859-69. PubMed ID: 22886598
[TBL] [Abstract][Full Text] [Related]
13. [Serotonin antagonism involved in the antipsychotic effect. Confirmation with ritanserine and risperidone].
Niemegeers CJ; Awouters F; Janssen PA
Encephale; 1990; 16(2):147-51. PubMed ID: 1693560
[TBL] [Abstract][Full Text] [Related]
14. Neuropharmacological profile of an atypical antipsychotic, NRA0562.
Hirota S; Kawashima N; Chaki S; Okuyama S
CNS Drug Rev; 2003; 9(4):375-88. PubMed ID: 14647530
[TBL] [Abstract][Full Text] [Related]
15. Cyclic benzamides as mixed dopamine D2/serotonin 5-HT2 receptor antagonists: potential atypical antipsychotic agents.
Norman MH; Rigdon GC; Navas F; Cooper BR
J Med Chem; 1994 Aug; 37(16):2552-63. PubMed ID: 7914539
[TBL] [Abstract][Full Text] [Related]
16. Piperidinyltetralin sigma ligands.
Gilligan PJ; Kergaye AA; Lewis BM; McElroy JF
J Med Chem; 1994 Feb; 37(3):364-70. PubMed ID: 7905926
[TBL] [Abstract][Full Text] [Related]
17. "Hit-and-run" actions at dopamine receptors, part 1: Mechanism of action of atypical antipsychotics.
Stahl SM
J Clin Psychiatry; 2001 Sep; 62(9):670-1. PubMed ID: 11681760
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of N-desmethylclozapine as a potential antipsychotic--preclinical studies.
Natesan S; Reckless GE; Barlow KB; Nobrega JN; Kapur S
Neuropsychopharmacology; 2007 Jul; 32(7):1540-9. PubMed ID: 17164815
[TBL] [Abstract][Full Text] [Related]
19. 5-HT6 receptor ligands and their antipsychotic potential.
Arnt J; Olsen CK
Int Rev Neurobiol; 2011; 96():141-61. PubMed ID: 21329787
[No Abstract] [Full Text] [Related]
20. Blonanserin extensively occupies rat dopamine D3 receptors at antipsychotic dose range.
Baba S; Enomoto T; Horisawa T; Hashimoto T; Ono M
J Pharmacol Sci; 2015 Mar; 127(3):326-31. PubMed ID: 25837930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
